Microsure logo — Robot-assisted microsurgery

Microsure

Robot-assisted microsurgery

Founded 2016 The Netherlands The Netherlands 65 employees Series B Total: $42.51M Health Care, Medical Devices

General Information

Company Name Microsure
Founded Year 2016
Location The Netherlands The Netherlands +1
Founders / Decision Makers
Team member
Employees 65
Industries Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when Microsure moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

AI Insight

Bounce Watch AI
1 month ago

Microsure is strategically preparing for the imminent launch and commercialization of its MUSA-3 microsurgical robot, supported by continued collaborations with key academic and medical institutions for clinical integration. The company is set to formally unveil MUSA-3 at EFSM 2026 with hands-on demonstrations, a significant market entry signal corroborated by a substantial recent website update. This coordinated effort points to a strong push for product scaling and adoption.

Signal Types
Product Launch Partnership Marketing Activity
Strategic Labels
Product Commercialization Clinical Integration Market Expansion
Next Move: Commercialization
·
Impact: 8/10
·
Ideal For: Surgical Robotics Growth Investors – Series B

About Microsure

Microsure, founded in 2016 and headquartered in The Netherlands, stands out in the Health Care and Medical Devices industries with its pioneering product: robot-assisted microsurgery. The company addresses the intricate challenges faced by supermicrosurgeons, who require precision at sub-millimeter levels, by continuously enhancing their high precision microsurgical robot.

The flagship product, MUSA-2, is celebrated as the first CE certified microsurgical robot, praised for features like scaled movements and tremor filtration. This innovation has been validated through various clinical studies and invaluable feedback has shaped the development of its successor, MUSA-3.

Backed by a robust €38.00M Series B investment on September 19, 2023, Microsystems secured funding from prominent investors, including BOM Brabant Ventures, European Innovation Council, Invest-NL, Kineo Finance, Innovation Industries, Eindhoven University of Technology, Ten Cate Investeringsmaatschappij, and VENTURING TECH. This funding solidifies Microsure's path towards revolutionizing the niche field of microsurgery, ensuring no patient is left without needed treatment.

Taxonomy: Robot-assisted Microsurgery, High Precision Robotics, Microsurgical Robots, Medical Device Innovation, Surgical Robotics Development, Tremor Filtration Technology, Ergonomic Surgical Solutions, Supermicrosurgery, Lymphedema Treatment, Motion Stabilization Systems, Surgical Outcomes Improvement, Reconstructive and Plastic Surgery, Advanced Surgical Procedures, MedTech Solutions, Clinical Trial Validation

Services & Products

development of microsurgical robots
enhancing precision in microsurgery
providing ergonomic surgical solutions
improving complex surgical procedures

Target Customers

microsurgeons plastic surgeons reconstructive surgeons medical centers specializing in microsurgery hospitals adopting robotic surgery

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 8
Investor Investor Investor Investor Investor
•••• ••••
19 Sep 2023
Grant •••••• 1
Investor
16 Jun 2021
Series B •••••• 1
Investor
29 Apr 2021
Venture Round •••••• - 30 Mar 2018

Microsure Alternatives & Competitors

View All Alternatives
Microsure vs
ROBODOC
ROBODOC United States

The ROBODOC Surgical System includes two leading-edge components: ORTHODOC®, a 3-dimensional worksta...

Series C
1 employees
Health Care, Manufacturing
Microsure vs

Advancing robotic technology for soft tissue open surgery at the micro level

Series C
320 employees
Health Care, Medical Devices
Microsure vs
Extend Robotics
Extend Robotics United Kingdom

The world's most intuitive human robot interface with to enable data flywheel for embodied physical...

Grant
22 employees
AI, Robotics

FAQ About Microsure

Robot-assisted microsurgery
Microsure was founded in 2016.
Microsure is headquartered in The Netherlands.
Microsure operates in the following industries: Health Care, Medical Devices.
Microsure has approximately 65 employees.
Microsure has completed 4 funding rounds, raising a total of $42.51M. The latest funding stage is Series B.
Microsure offers: development of microsurgical robots, enhancing precision in microsurgery, providing ergonomic surgical solutions, improving complex surgical procedures.
Top alternatives and competitors to Microsure include ROBODOC, MMI - Medical Microinstruments, Inc., Extend Robotics, CHENGDU CRP ROBOT TECHNOLOGY CO.,LTD., Brain Navi Biotechnology Co., Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Microsure and ROBODOC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Microsure and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy